戻る Agenda
The Environment for Health Care Decision-making: Collecting, Using and Understanding Comparative Effectiveness Research
Session Chair(s)
Kimberly Westrich, MA
Director, Health Services Research
National Pharmaceutical Council, United States
This session will provide an overview of how stakeholders view the environment for health care decision-making, an in-depth look at how payers view and use comparative effectiveness research (CER) studies for these decisions, and an innovative way to collect the patient data needed for these CER studies.
Learning Objective : Describe stakeholder views on the impact of comparative effectiveness research (CER) for health care decision-making; Discuss how payers consider and use CER to make decisions; Define models for collection of real-world, observational data directly through patients.
Speaker(s)
Monitoring Changes in the Environment for Health Care Decision-making
Kimberly Westrich, MA
National Pharmaceutical Council, United States
Director, Health Services Research
Translating CER into Medical Payment Policy: Views from Public and Private Payers
Joel S. Weissman, PHD
Harvard Medical School, United States
Associate Professor, Health Policy
Working Directly with Patients to Collect HEO/CER Data Using Innovative Hybrid Observational Research Models
John Reites
THREAD, United States
Chief Executive Officer